LSA
PPH icon

Lansing Street Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Lansing Street Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,978
Closed -$516K – 141
2024
Q4 		$516K Sell
5,978
-2,821
-32% -$255K 0.18% 68
2024
Q3 		$836K Buy
8,799
+35
+0.4% +$3.32K 0.31% 49
2024
Q2 		$802K Sell
8,764
-2,306
-21% -$206K 0.33% 49
2024
Q1 		$1M Sell
11,070
-3,465
-24% -$303K 0.45% 42
2023
Q4 		$1.18M Buy
+14,535
New +$1.14M 0.62% 35
2023
Q2 		$1.91M Sell
24,253
-1,237
-5% -$96.8K 1.11% 23
2023
Q1 		$1.98M Sell
25,490
-820
-3% -$63.2K 1.24% 23
2022
Q4 		$2.05M Sell
26,310
-5,923
-18% -$437K 1.4% 21
2022
Q3 		$2.17M Buy
32,233
+9,418
+41% +$694K 1.68% 15
2022
Q2 		$1.75M Buy
22,815
+2,572
+13% +$201K 1.36% 19
2022
Q1 		$1.7M Buy
+20,243
New +$1.55M 1.08% 25

Other funds holding PPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Lansing Street Advisors's PPH Position: Q1 2025 in Review

Lansing Street Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 5,978 shares — an estimated $516K sold.

Lansing Street Advisors first reported a position in PPH in Q1 2022 and held it in 11 quarters. The position peaked at $2.17M in Q3 2022. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

  • Lansing Street Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
  • Lansing Street Advisors sold 5,978 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $516K.
  • Lansing Street Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and held it in 11 quarters.
  • Lansing Street Advisors's VanEck Pharmaceutical ETF position peaked at $2.17M in Q3 2022.
  • 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Lansing Street Advisors's 13F filing for Q1 2025, filed 28 Apr 2025.